Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Neoplasm Metastasis
×
Folic Acid
×
Clear all
Filters
3
NCT04786964
2025-04-02
CONTERNO
Checkpoint Therapeutics, Inc.
Phase 3
Terminated
25 enrolled
10 charts